RJA
NUVL

Raymond James & Associates’s Nuvalent NUVL Stock Holding History

Raymond James & Associates’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$886K Buy
8,661
+4,020
+87% +$333K ﹤0.01% 2767
2024
Q2 		$352K Sell
4,641
-49
-1% -$3.48K ﹤0.01% 3274
2024
Q1 		$352K Buy
+4,690
New +$373K ﹤0.01% 3289

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Raymond James & Associates's NUVL Position: Q3 2024 in Review

Raymond James & Associates increased its Nuvalent (NUVL) stake by 87% in Q3 2024, buying an estimated $333K and bringing the position to 8,661 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Raymond James & Associates first reported a position in NUVL in Q1 2024 and has held it in 3 quarters since. 193 funds tracked by Wall St. Rank hold NUVL as of Q3 2024.

  • Raymond James & Associates held 8,661 shares of Nuvalent worth $886K as of Q3 2024.
  • Raymond James & Associates bought 4,020 Nuvalent shares in Q3 2024, an estimated $333K.
  • Nuvalent made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2767 holding.
  • Raymond James & Associates first reported a position in Nuvalent in Q1 2024 and has held it in 3 quarters since.
  • 193 funds tracked by Wall St. Rank held Nuvalent as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.